- Home
- ORIS vs MIRA Comparison
ORIS vs MIRA Comparison
Compare ORIS & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORIS | MIRA |
|---|---|---|
| Founded | 2014 | 2020 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.0M | 50.3M |
| IPO Year | 2024 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ORIS | MIRA |
|---|---|---|
| Price | $1.42 | $1.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 479.4K | 156.7K |
| Earning Date | 04-30-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $12,317,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $171.74 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.11 | $0.73 |
| 52 Week High | $45.60 | $2.45 |
Technical Indicators
Market Signals| Indicator | ORIS | MIRA |
|---|---|---|
| Relative Strength Index (RSI) | 53.13 | 32.92 |
| Support Level | $1.11 | $1.16 |
| Resistance Level | $1.30 | $1.25 |
| Average True Range (ATR) | 0.12 | 0.07 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 34.62 | 15.38 |
Price Performance
Historical ComparisonAbout ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.